Johnson & Johnson Highlighted as Hedge After Health Care’s 7% Drop Versus 20% Tech Rally
Jim Cramer recommends health care stocks including Johnson & Johnson as a portfolio hedge given sector’s 7% decline versus technology’s 20% gain last quarter. He cites Johnson & Johnson’s robust drug pipeline and earnings resilience as key appeals outside AI-driven rallies.
1. Cramer’s Hedge Recommendation
Jim Cramer warns that concentrated AI-driven gains in tech could reverse and recommends diversifying with health care stocks as a defensive strategy.
2. Health Care vs Tech Performance
Health care sector fell over 7% last quarter while technology stocks surged more than 20%, highlighting a significant valuation gap between the sectors.
3. Johnson & Johnson’s Pipeline Appeal
Johnson & Johnson’s extensive drug pipeline and consistent earnings growth underpin its selection as a hedge outside the AI-driven market rally.
4. Other Stocks in the Sector
Cramer also cited CVS Health, Cardinal Health and UnitedHealth Group for their retail pharmacy positioning, distribution growth initiatives and scale advantages.